false 0000803578 0000803578 2024-10-29 2024-10-29
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 29, 2024
 
 
 
FIREFLY NEUROSCIENCE, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
 
 
Delaware
  
001-41092
  
54-1167364
(State or other jurisdiction
of incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
 
 
1100 Military Road
Kenmore, NY
  
14217
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: 888-237-6412
 
 
(Former name or former address, if changed since last report)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
Common Stock, $0.0001 par value per share
  
AIFF
  
The Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
 
 
Item 4.01
Changes in Registrant’s Certifying Accountant.
 
(a) Dismissal of Independent Registered Public Accounting Firm
 
On October 29, 2024, the Audit Committee (the “Audit Committee”) of the Board of Directors of Firefly Neuroscience, Inc. (the “Company”) dismissed Turner, Stone & Company LLP (“Turner Stone”) as the Company’s independent registered public accounting firm, effective immediately.
 
The reports of Turner Stone on the Company’s consolidated financial statements for the years ended December 31, 2023, and December 31, 2022, did not contain an adverse opinion or a disclaimer of opinion, and was not qualified or modified as to uncertainty, audit scope, or accounting principles, except that Turner Stone’s reports for the years ended December 31, 2023, and December 31, 2022, each contained an explanatory paragraph stating there was substantial doubt about the Company’s ability to continue as a going concern.
 
During the two most recent fiscal years ended December 31, 2023, and December 31, 2022, and the subsequent interim period through October 29, 2024, there were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K of the Securities Exchange Act of 1934, as amended (“Regulation S-K”) and the related instructions to Item 304 of Regulation S-K) with Turner Stone on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Turner Stone, would have caused Turner Stone to make reference to the subject matter of the disagreements in connection with its reports on the Company’s consolidated financial statements for such years. Also during this time, there were no “reportable events,” as defined in Item 304(a)(1)(v) of Regulation S-K.
 
The Company provided Turner Stone with a copy of the above disclosures and requested that Turner Stone furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made above. A copy of Turner Stone’s letter dated October 31, 2024, is attached as Exhibit 16.1 to this Current Report on Form 8-K.
 
(b) Appointment of New Independent Registered Public Accounting Firm
 
On October 31, 2024, the Audit Committee engaged Marcum Canada, LLP (“Marcum”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, effective immediately. During the fiscal years ended December 31, 2023, and December 31, 2022, and the subsequent interim period through October 31, 2024, neither the Company nor anyone on its behalf has consulted with Marcum regarding (i) the application of accounting principles to any specified transaction, either completed or proposed or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written report nor oral advice was provided to the Company that Marcum concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a “disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K, or a “reportable event,” as defined in Item 304(a)(1)(v) of Regulation S-K.
 
Item 9.01
Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
  
Description of Exhibit
16.1
  
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
   
FIREFLY NEUROSCIENCE, INC.
     
Date: November 1, 2024
By:
/s/ Jon Olsen
 
Name:
Jon Olsen
 
Title:
Chief Executive Officer
 
 

Exhibit 16.1

 

logo.jpg

 

 

October 31, 2024


Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561


Dear Sirs/Madams:


We have read Item 4.01 of Firefly Neuroscience, Inc. Form 8-K dated October 29, 2024, and have the following comments:

 

1.

We agree with the statements made in the first through fourth paragraphs.

 

2.

We have no basis on which to agree or disagree with the statements in the fifth paragraph.

 

Yours truly,

 

/s/ Turner, Stone & Company, L.L.P.

 

 

 

 

footer.jpg

 

 
v3.24.3
Document And Entity Information
Oct. 29, 2024
Document Information [Line Items]  
Entity, Registrant Name FIREFLY NEUROSCIENCE, INC.
Document, Type 8-K
Document, Period End Date Oct. 29, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-41092
Entity, Tax Identification Number 54-1167364
Entity, Address, Address Line One 1100 Military Road
Entity, Address, City or Town Kenmore
Entity, Address, State or Province NY
Entity, Address, Postal Zip Code 14217
City Area Code 888
Local Phone Number 237-6412
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol AIFF
Security Exchange Name NASDAQ
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000803578
Firefly Neuroscience (NASDAQ:AIFF)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Firefly Neuroscience Charts.
Firefly Neuroscience (NASDAQ:AIFF)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Firefly Neuroscience Charts.